SCHEMBL139279

SCHEMBL139279

CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 11/20 1.00
LMNA P02545 3/20 1.00
NR3C1 P04150 5/20 0.80
SMN1; SMN2 Q16637 4/20 0.80
CYP2C19 P33261 3/20 0.80
HSD17B10 Q99714 3/20 0.80
SERPINA6 P08185 3/20 0.80
CYP3A4 P08684 3/20 0.80
MAPT P10636 3/20 0.80
PGR P06401 2/20 0.80
SHBG P04278 2/20 0.80
KMT2A Q03164 2/20 0.80
NFKB1 P19838 2/20 0.80
NR3C2 P08235 1/20 0.80
AR P10275 1/20 0.76
CHRM1 P11229 1/20 0.76
MEN1 O00255 1/20 0.71
ADORA3 P0DMS8 1/20 0.71
MAPK3 P27361 1/20 0.71
BLM P54132 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19327109 1.00 HIF1A (1.00) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL139280 1.00 HIF1A (1.00) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL13754708 1.00 HIF1A (1.00) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL3940262 1.00 HIF1A (1.00) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL2507571 1.00 HIF1A (1.00) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL14523057 1.00 HIF1A (1.00) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL1626384 0.92 HIF1A (0.84) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL1626382 0.92 HIF1A (0.84) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL2484782 0.92 HIF1A (0.84) HIF1ALMNANR3C1SMN1; SMN2CYP2C19
SCHEMBL13147966 0.92 HIF1A (0.84) HIF1ALMNANR3C1SMN1; SMN2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3320 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260148848-A1 BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2026-05-28 US claimed
US-20250279209-A1 PROVISION OF A MEDICAL RISK ASSESSMENT FOR NONCLASSICAL 21-HYDROXYLASE DEFICIENCY UNIV SORBONNE (FR) 2025-09-04 US claimed
US-20250231202-A1 METHOD FOR PREDICTING THE POSTOPERATIVE RISK OF BRAIN-INJURED PATIENTS AND THE USE OF STEROIDS/PROTEINS FOR PREDICTING THE POSTOPERATIVE RISK OF BRAIN-INJURED PATIENTS TAIPEI MEDICAL UNIVERSITY (TW) 2025-07-17 US claimed
EP-4562182-A1 BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2025-06-04 EP claimed
CN-115963199-B Quantitative detection method and application of steroid hormone in human/animal body fluid 上海鹿明生物科技有限公司 2025-04-29 CN claimed
WO-2025049529-A1 RECOMBINANT HOST CELLS, POLYPEPTIDES AND PROCESSES FOR BIOSYNTHESIS OF HYDROCORTISONE EPIMERON USA, INC. (US) 2025-03-06 WO claimed
EP-4511660-A1 PROVISION OF A MEDICAL RISK ASSESSMENT FOR NONCLASSICAL 21-HYDROXYLASE DEFICIENCY SORBONNE UNIVERSITE (FR) 2025-02-26 EP claimed
US-20250041208-A1 NEW INJECTABLE COMBINATION FORMULATION NANEXA AB (SE) 2025-02-06 US claimed
CN-119125354-A Method and kit for measuring various steroid hormones in body fluid by liquid chromatography-mass spectrometry technology 浙江博圣生物技术股份有限公司 2024-12-13 CN claimed
CN-119125357-A Kit for simultaneously detecting multiple steroid hormones in dried blood spots based on liquid chromatography-mass spectrometry and application of kit 浙江博圣生物技术股份有限公司 2024-12-13 CN claimed
CN-1599613-A Combination therapy for the treatment of immunoinflammatory disorders COMBINATORX INC (US) 2005-03-23 CN claimed
EP-1448205-A2 COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS Combinatorx, Incorporated (US) 2004-08-25 EP claimed
US-20040072732-A1 Use of ramoplanin to treat diseases associated with the use of antibiotics NANOSHIFT, LLC 2004-04-15 US claimed
WO-2003103699-A1 USE OF RAMOPLANIN TO TREAT DISEASES ASSOCIATED WITH THE USE OF ANTIBIOTICS VICURON PHARMACEUTICALS INC. (US) 2003-12-18 WO claimed
WO-2003092617-A2 COMBINATIONS FOR THE TREATMENT OF INFLAMMATORY SKIN DISORDERS COMBINATORX, INCORPORATED (US) 2003-11-13 WO claimed
US-20030119786-A1 Combinations for the treatment of immunoinflammatory disorders ZALICUS INC. 2003-06-26 US claimed
WO-2003030823-A2 COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS COMBINATORX, INCORPORATED (US) 2003-04-17 WO claimed
WO-1997038015-A1 ARTIFICIAL ANTIBODIES TO CORTICOSTEROIDS PREPARED BY MOLECULAR IMPRINTING IGEN, INC. (US) 1997-10-16 WO claimed
EP-0054390-B1 DEHALOGENATION OF STEROIDS THE UPJOHN COMPANY (US) 1984-07-25 EP claimed
US-4325881-A Debromination THE UPJOHN COMPANY (US) 1982-04-20 US claimed